Tivozanib
Product Specifications
CAS Number
475108-18-0
Target
PDGFR, Ephrin Receptor, VEGFR
Related Pathways
Tyrosine Kinase/Adaptors, Angiogenesis
Purity
0.9967
Bioactivity
Tivozanib (KRN951) is an orally bioavailable inhibitor of vascular endothelial growth factor receptors (VEGFRs) 1, 2 and 3 with potential antiangiogenic and antineoplastic activities.
Smiles
O(C=1C2=C(C=C(OC)C(OC)=C2)N=CC1)C3=CC(Cl)=C(NC(NC=4C=C(C)ON4)=O)C=C3
Molecular Formula
C22H19ClN4O5
Molecular Weight
454.86
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6495522-01 0.2 mL
PPP2R3L, NT (Serine/Threonine-protein Phosphatase 2A Regulatory Subunit B'' Subunit beta, PP2A Subunit B Isoform PR48, Protein Phosphatase 2A 48kD Regulatory Subunit, PR48) (APC)
Sign In for Pricing
View Details MBS6495522-02 5x 0.2 mL
PPP2R3L, NT (Serine/Threonine-protein Phosphatase 2A Regulatory Subunit B'' Subunit beta, PP2A Subunit B Isoform PR48, Protein Phosphatase 2A 48kD Regulatory Subunit, PR48) (APC)
Sign In for Pricing
View Details CSB-MP013493MO-01 20 µg
Recombinant Mouse Myristoylated alanine-rich C-kinase substrate (Marcks)
Sign In for Pricing
View Details CSB-MP013493MO-02 100 µg
Recombinant Mouse Myristoylated alanine-rich C-kinase substrate (Marcks)
Sign In for Pricing
View Details CSB-MP013493MO-03 1 mg
Recombinant Mouse Myristoylated alanine-rich C-kinase substrate (Marcks)
Sign In for Pricing
View Details 